Four decades after the discovery of HIV-1, the retrovirus that cause AIDS, a vaccine still eludes researchers because of the virus' complex and challenging biology. HIV-1 evolves about 1 million times ...

The second HIV or human immunovirus patient, dubbed as the "Esperanza Patient," has been cleared of the virus and it is due to natural causes or not resorting to the different treatments by modern ...

SEATTLE – March 29, 2012 – Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody ...

Most HIV drugs act on enzymes the virus needs throughout its life cycle, but none specifically target the capsid, a shell that protects the virus' genetic material and delivers it to cells. Scientists ...

Cholesterol is instrumental in HIV's ability to infiltrate cells, and removing this fatty material from a cell's membrane blocks infection, according to a Johns Hopkins study reported in the July 20th ...

Philadelphia, PA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the ...

About 1.5 million new HIV infections are thought to have occurred last year, and while COVID-19 has dominated concerns about public health in recent years, HIV remains a threat to many people. Human ...

AIDS is one of the most significant pubic health challenges worldwide. Professor of biochemistry Wesley Sundquist, Ph.D., researches how HIV - the retrovirus that causes AIDS - infects the body, with ...

Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host’s ...

Instead, the scientists focused on genes already suspected to influence HIV biology. In particular, they used the genes encoding a large number of human proteins that the Krogan lab had previously ...